A retrospective cohort study evaluating efficacy in high-risk patients with chronic lower extremity ulcers treated with negative pressure wound therapy

International Wound Journal

Volumn 11, Issue 5, 2014, Pages 483-488

  Yao, Min ^a,b,d   Fabbi, Matteo ^a,d   Hayashi, Hisae ^a,d   Park, Nanjin ^a,d   Attala, Khaled ^a,d   Gu, Gousheng ^a,d   French, Michael A ^a,d   Driver, Vickie R ^a,b,c  

^a VA New England Health Care Division   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c Brown/VA Center for Restorative and Regenerative Medicine   (United States)

^d Limb Preservation Research and Fellowship Program   (United States)

Author keywords

Comorbidities; Early intervention; Low extremity chronic ulcers; Negative pressure wound therapy; Wound healing

Indexed keywords

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; DISEASE SEVERITY; EARLY INTERVENTION; FEMALE; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; LEG ULCER; LOWER EXTREMITY ULCER; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN ULCER; SMOKING; ULCER; ULCER HEALING; VACUUM ASSISTED CLOSURE; WOUND CLOSURE; WOUND HEALING; AGE; AGED; CEREBROVASCULAR DISORDERS; CHRONIC DISEASE; COMPARATIVE STUDY; CORONARY DISEASE; HEART FAILURE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; SEX DIFFERENCE; TIME; TREATMENT OUTCOME;

AGE FACTORS; AGED; CEREBROVASCULAR DISORDERS; CHRONIC DISEASE; COHORT STUDIES; COMORBIDITY; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; HEART FAILURE; HUMANS; LEG ULCER; MALE; MIDDLE AGED; NEGATIVE-PRESSURE WOUND THERAPY; PERIPHERAL ARTERIAL DISEASE; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME; WOUND HEALING;

EID: 84927913513     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2012.01113.x     Document Type: Article

References (32)

1. Armstrong DG. Discussion. Update on negative-pressure wound therapy. Plast Reconstr Surg 2011;127(Suppl 1):116S.
2. Andros G, Armstrong DG, Attinger CE, Boulton AJ, Frykberg RG, Joseph WS, Lavery LA, Morbach S, Niezgoda JA, Toursarkissian B; Tucson Expert Consensus Conference. Consensus statement on negative pressure wound therapy (V.A.C. Therapy) for the management of diabetic foot wounds. Ostomy Wound Manage 2006;Suppl:1-32.
3. Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 2005;366:1704-10.
4. DeFranzo AJ, Pitzer K, Molnar JA, Marks MW, Chang MC, Miller PR, Letton RW, Argenta L. Vacuum-assisted closure for defects of the abdominal wall. Plast Reconstr Surg 2008;121:832-9.
5. Page JC, Newswander B, Schwenke DC, Hansen M, Ferguson J. Retrospective analysis of negative pressure wound therapy in open foot wounds with significant soft tissue defects. Adv Skin Wound Care 2004;17:354-64.
6. Orgill DP, Bayer LR. Update on negative-pressure wound therapy. Plast Reconstr Surg 2011;127Suppl 1:105S-15S.
7. Blume PA, Walters J, Payne W, Ayala J, Lantis J. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care 2008;31:631-6.
8. Banwell PE. Topical negative pressure therapy in wound care. J Wound Care 1999;8:79-84.
9. McNulty AK, Schmidt M, Feeley T, Kieswetter K. Effects of negative pressure wound therapy on fibroblast viability, chemotactic signaling, and proliferation in a provisional wound (fibrin) matrix. Wound Repair Regen 2007;15:838-46.
10. Schultz GS, Davidson JM, Kirsner RS, Bornstein P, Herman IM. Dynamic reciprocity in the wound microenvironment. Wound Repair Regen 2011;19:134-48.
11. Lantis Ii JC. Update 2012: regenerative medicine in wounds: current use of growth factors, cell therapy, and negative pressure wound therapy for chronic wounds. Surg Technol Int 2011;XXI:43-49.
12. Wu SC, Marston W, Armstrong DG. Wound care: the role of advanced wound-healing technologies. J Am Podiatr Med Assoc 2010;100:385-94.
13. Gottrup F, Apelqvist J, Price P. Outcomes in controlled and comparative studies on non-healing wounds: recommendations to improve the quality of evidence in wound management. J Wound Care 2010;19:237-68.
14. Horn SD, Gassaway J. Practice-based evidence study design for comparative effectiveness research. Med Care 2007;45(10 Suppl 2):S50-S7.
15. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-92.
16. Carter MJ, Fylling CP, Li WW, de Leon J, Driver VR, Serena TE, Wilson J. Analysis of run-in and treatment data in a wound outcomes registry: clinical impact of topical platelet-rich plasma gel on healing trajectory. Int Wound J 2011;8:638-50.
17. Bagshaw SM, Bellomo R. The need to reform our assessment of evidence from clinical trials: a commentary. Philos Ethics Humanit Med 2008;3:23.
18. Kaplan M, Daly D, Stemkowski S. Early intervention of negative pressure wound therapy using vacuum-assisted closure in trauma patients: impact on hospital length of stay and cost. Adv Skin Wound Care 2009;22:128-32.
19. Braakenburg A, Obdeijn MC, Feitz R, van Rooij IA, van Griethuysen AJ, Klinkenbijl JH. The clinical efficacy and cost effectiveness of the vacuum-assisted closure technique in the management of acute and chronic wounds: a randomized controlled trial. Plast Reconstr Surg 2006;118:390-97(discussion 398-400).
20. Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg 2010;52(3 Suppl):17S-22S.
21. Driver VR, Madsen J, Goodman RA. Reducing amputation rates in patients with diabetes at a military medical center: the limb preservation service model. Diabetes Care 2005;28:248-53.
22. Driver VR, Yao M. Discussion. The economics of limb salvage in diabetes. Plast Reconstr Surg 2011;127(Suppl 1):296S-97S.
23. Stockl K, Vanderplas A, Tafesse E, Chang E. Costs of lower-extremity ulcers among patients with diabetes. Diabetes Care 2004; 27:2129-34.
24. Wu SC, Armstrong DG. Clinical outcome of diabetic foot ulcers treated with negative pressure wound therapy and the transition from acute care to home care. Int Wound J 2008;5(Suppl 2):10-16.
25. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 2003;26:1790-5.
26. Marston W. Evaluation and treatment of leg ulcers associated with chronic venous insufficiency. Clin Plast Surg 2007;34:717-30.
27. Marston WA, Carlin RE, Passman MA, Farber MA, Keagy BA. Healing rates and cost efficacy of outpatient compression treatment for leg ulcers associated with venous insufficiency. J Vasc Surg 1999;30:491-8.
28. Robertson L, Evans C, Fowkes FG. Epidemiology of chronic venous disease. Phlebology 2008;23:103-11.
29. Van den Oever R, Hepp B, Debbaut B, Simon I. Socio-economic impact of chronic venous insufficiency. An underestimated public health problem. Int Angiol 1998;17:161-7.
30. vonKoss Krowchuk H, Moore ML, Richardson L. Using health care records as sources of data for research. J Nurs Meas 1995;3:3-12.
31. Worster A, Haines T. Advanced statistics: understanding medical record review (MRR) studies. Acad Emerg Med 2004;11:187-92.
32. Wu L, Ashton CM. Chart review. A need for reappraisal. Eval Health Prof 1997;20:146-63.